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This systematic review aimed to generate evidence on role of potent markers of inflammation [cytokines,
chemokines, their associated receptors and antagonists] following the application of orthodontic forces. Subsequent
to registration with PROSPERO, literature search followed a predetermined search strategy to key databases along with
hand search (HS). Seventy-seven articles from PubMed (P), 637 from Scopus (S), 51 from Embase (E), and 3 from
hand search (HS) were identified. A total of 39 articles were shortlisted that met strict inclusion and exclusion criteria
and quality assessment. Each study was evaluated for participant characteristics, study design, oral hygiene regimen,
and gingival crevicular fluid (GCF) handling. Among these studies, biomarkers in the order of frequency were interleukin
(IL)-1β (N = 21), tumor necrosis factor (TNF)-α (N = 10), IL-8,IL-6(N=8), receptor activator of nuclear factor kappa-B ligand
(RANKL) (N = 7), monocyte chemoattractant protein (MCP)-1 (N = 3), IL-2 (N=4), IL-4, IL-10, RANTES (N = 2), IL-1, IL-5,
IL-1α, IP-10, osteopontin (OPN) (N = 1) and receptors and their antagonists in the order of osteoprotegerin (OPG)
(N = 8), IL-1RA (N = 5), and RANK (N = 1). Results revealed an immediate release of inflammatory bone-resorptive
mediators, IL-1β and TNF-α, where IL-1β increased as early as 1 min to 1 h reaching peak at 24 h while TNF-α increased
at 1 h or 1 day. This was accompanied by a fall in bone-protective mediator (OPG) levels at 1 h and 24 h after orthodontic
force application. Continuous forces were accompanied by a decrease in mediator levels after attaining peak levels (most
commonly at 24 h) while repeated activations in interrupted force upregulated their secretion. Significant correlations of
IL-1β levels with pain intensity, rate of orthodontic tooth movement (OTM) and of activity index (AI) (IL-1β/IL-1RA) with
velocity of tooth movement and growth status of individuals have also been deduced. A greater AI and RANKL/OPG ratio
was seen in juveniles as compared to adults or non-growers that were associated with faster rate of OTM in juveniles.
None of the studies addressed the effect of estrous cycle in female subjects. Lack of homogeneity in several parameters
calls for a better controlled research on the biology of OTM.
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Background
Orthodontic tooth movement (OTM) is considered an
epiphenomenon of the gene expression of the periodon-
tal ligament (PDL) and neighboring cells resulting from
a series of orchestrated cellular and molecular events in
alveolar bone and periodontal tissue initiated by the ap-
plication of orthodontic force [1]. A chemical cascade* Correspondence: opk15@hotmail.com
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in any medium, provided the original work is pthat mediates the transmission of signals from extracel-
lular matrix leading to genetic modulation is interceded
by the release of mediators in paracrine environment.
These signals are responsible for a change in the cyto-
skeletal structure, leading to alteration of nuclear protein
matrix and eventually gene activation or suppression [2,3].
These events initiate the process of bone remodeling,
leading to effective tooth movement. The biochemical me-
diators released sequentially at multiple stages during or-
chestration of tooth movement can be detected in gingival
crevicular fluid (GCF). GCF is a unique biological exudate
that has been found as a convenient medium to study
these mediators with reasonable sensitivity. GCF can bean Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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paper or a micropipette (1 to 10 μl) or through magnetic
beads placed in gingival crevice. GCF once collected may
be cryopreserved or directly sent for chemical analysis.
GCF can also be collected repeatedly at various stages of
orthodontic treatment and therefore provides useful
insight to biological events over the entire duration of
observation.
Clinically demonstrable success of OTM is associated
with expression of numerous regulatory molecules, of
which cytokines have been most widely documented.
Cytokines are low-molecular weight proteins (mw <
25 kDa) released in autocrine or paracrine environment
in response to local signals like application of stress [5]
and are involved in normal physiological bone turnover
and remodeling [6-8]. Cytokine biology as a retort to
forces applied for OTM is difficult to comprehend due to
sheer number and complexity of these factors exhibiting
redundancy as well as pleiotropy [9]. Although cytokines
have been extensively evaluated in GCF as quantitative
biochemical indicators of inflammatory periodontal status
[10], there has been an increasing interest on understand-
ing their contributions as mediators of OTM owing to
their role in bone and tissue remodeling. Among these
cytokines, interleukins (ILs) (IL-1α, IL-1β, IL-1RA, IL-8,
IL-2, IL-6, and IL-15), tumor necrosis factors (TNFs),
interferons (IFNs), growth factors (GFs), and colony-
stimulating factors (CSFs) have been extensively stud-
ied in relation to OTM.
The secretion of these mediators in the local environ-
ment by cells activated on application of orthodontic
force varies according to the force levels and functional
state of available target cells. The rate of OTM depends
on recruitment of mature osteoclasts and precursors,
osteoclast differentiation and number of functional oste-
oclasts at the bone-PDL interface, where bone resorption
is considered a rate-limiting step [11]. The earliest identi-
fied marker of bone resorption is IL-1β, closely followed
by prostaglandin E2 (PGE2), nitric oxide, IL-6, and other
inflammatory cytokines [12]. TNF is also believed to
have synergistic effects with IL-1 [13]. Osteoclast dif-
ferentiation and activation is mediated by the binding
of receptor activator of nuclear factor kappa-B to its
ligand expressed by osteoblasts and PDL cells (RANK
and RANKL, respectively) [11,14-16]. This interaction
and osteoclast activity is prevented by a decoy receptor for
RANKL called osteoprotegerin (OPG) [17]. Thus, the rela-
tive balance between RANK-RANKL and OPG may be
critical to the magnitude and rate of OTM.
The first experimental evidence supporting role of cy-
tokines in OTM was documented in periodontal tissues
of cat canine teeth where IL-1α and IL-1β were identi-
fied after the application of a tipping force [18]. One of
the earliest noninvasive studies on IL-1β in GCF wasdone by Grieve et al. [19] where significant elevations
from baseline in IL-1β and PGE levels supported initial
release of proinflammatory mediators on application of
orthodontic forces, followed by a decrease in 7 days (d).
Since then, numerous studies in humans have focused
on alterations in IL-1β levels in GCF in an attempt to
understand the underlying inflammatory process during
OTM. The studies have now diversified to include other
interleukins like IL-1α, IL-2, IL-6, IL-8, and receptor an-
tagonist IL-1RA. More recently, the presence of other me-
diators including TNF-α, TGF-β, leptin, RANK/RANKL,
and OPG have also been explored in OTM.
This systematic review aims to determine effect of
orthodontic forces on levels of markers of inflammation
namely cytokines, chemokines, receptors and their antag-
onists, which have been widely documented in GCF. The
present study looks into literature to generate evidence on
the role of these mediators in relation to the force levels,
applied mechanics, age, sex and pain intensity during
orthodontic treatment. This systematic review provides in-
sights into possible biomarkers for tooth movement and
their potential contributions to modulating orthodontic
bone turnover that could prove useful in designing future
approaches to modulating OTM.Material and methods
This review was registered in PROSPERO on 3 June,
2014 (registration number CRD42014009302). The sys-
tematic review was conducted strictly adhering to guide-
lines suggested by PROSPERO. A search strategy was
finalized utilizing MESH terms, Boolean terminology,
and free text terms (Additional file 1: Annexure 1). This
search strategy was applied to key databases PubMed,
Scopus, and Embase in April 2014 by two reviewers PK
and NM which followed a cross check by third reviewer
OPK. Apart from that, hand search of journals was per-
formed for article retrieval. Segregation of articles to be
considered for review was based on stringent inclusion
and exclusion criteria. Seventy-seven articles in PubMed,
637 in Scopus, 51 in Embase, and 3 from hand searching
were retrieved (Figure 1). Duplicates were removed be-
fore final screening of articles for inclusion in the review.
The titles and abstracts of these manuscripts were stud-
ied, considering exclusion and inclusion criteria specific
to each database (Figure 1). The relevant articles were ob-
tained. These were PubMed - 41, Scopus - 17, Embase - 2
and hand searched - 3. Further, a few articles had to be ex-
cluded for non-availability of full text. These were
PubMed (N = 4), Scopus (N = 15), and Embase (N = 1).
Further, four articles had to be excluded since full text re-
vealed no mention of orthodontic force (N = 1) or study
was not performed in crevicular fluid (N = 3). A consensus
has arrived among reviewers for final inclusion of 39
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from Scopus, 1 from Embase, and 3 from hand search
(Figure 1).
The inclusion and exclusion criterion were as under.
Inclusion Criteria:
Participants/population -Human studies, age groups
(if specified), male to female ratio (if specified),
controls (either internal where baseline levels are
taken as control or external where contralateral orFigure 1 Flowchart depicting the retrieval of studies for review processantagonistic tooth is taken as control), sample size
>5 (refers to sample size not number of teeth
studied).
Intervention(s), exposure(s)-Studies on cytokines
[including interleukins (ILs), tumor necrosis factor
(TNF) and growth factors (GFs), colony-stimulating
factors (CSFs), interferons (IFNs)], chemokines,
receptors and their antagonists (RANK, RANKL,
OPG, OPN) with specified orthodontic mechanics,
proper oral hygiene control, no use of antibiotic/
anti-inflammatory drugs before or during.
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collection via periopaper or micropipette
placed in sulcus.
Exclusion criteria
Participants/population- In vitro studies, animal
studies, sample size <5, no control. Intervention(s),
exposure(s)- Studies on mediators other than
cytokines or chemokines or receptors, cytokine or
chemokine or receptor measurement in periodontal
tissue and not GCF, cytokine or chemokine or
receptor levels consequent to periodontal
inflammation and not orthodontic force application,
cytokine levels measured in peri-implant fluid.
This is a followed data extraction by two reviewers
(PK and NM). The data was recorded in a tabular form
based on the following criteria:
1. Participant characteristics (Table 1): number of
study subjects (not the number of teeth), teeth
considered for study (if specified), sites (if
mentioned), age of study subjects (either range or
mean age ± standard deviation (SD)), sex, controls,
and studied mediators. Apart from these, following
inclusion criteria were also considered (if
mentioned) no history of drug intake, no bone loss,
no gingival inflammation, and pocket depth <2 mm.
2. Study characteristics (Table 2): these were nature of
applied force, force magnitudes, force reactivations
(if studied), total study duration, observation
intervals, and type of tooth movement.
3. Oral hygiene regimen and assessment of gingival
health (Table 3): recommendation and frequency of
mouthwash intake, oral prophylaxis schedule, use of
indices for gingival and periodontal assessment, and
their frequency.
4. GCF characteristics (Table 4): time, room
temperature and humidity during GCF collection,
site, method of collection of GCF, storage and
handling characteristics, and technique of mediator
analysis.
Quality assessment of the articles included in the review
was done based on a Quality Assessment Instrument
(QAI) modified and developed from relevant articles in lit-
erature [20,21] given in Additional file 2: Annexure 2.
Thirty stringent criteria for evaluation of quality in-
cluded relevant study design (N = 19), study measure-
ments (N = 3), statistical analysis (N = 5), study results,
and conclusions (N = 3). (Additional file 2: Annexure 2).
For objective assessment of quality determination, a scor-
ing system was incorporated where scores of 1 to 10 wereconsidered minimal, 10 to 20 were considered moderate,
and 20 to 30 were considered highly sensitive. QAI re-
vealed 26 moderately sensitive and 13 highly sensitive
studies. None of the studies fell in the score of 1 to 10.
The results were compiled after grouping of observa-
tions from similar studies to arrive at conclusions with
relevant clinical implications.
Results
Thirty-nine shortlisted studies [19,22-59] were scruti-
nized for inclusion and exclusion criteria. Two studies
that evaluated mediators both in peri-implant crevicular
fluid (PMICF) as well as GCF were included [51,54] but
one study that evaluated the levels of mediators directly
in sulcus and not GCF was excluded [60].
The studies were categorized based on participant
characteristics (Table 1), study characteristics (Table 2),
oral hygiene regimen and assessment of gingival health
(Table 3), and GCF characteristics (Table 4). All studies
displayed control, either internal/external. The levels of
biomarkers assessed at baseline level (0 day) were taken
as control in the former while in the later, contralateral
or antagonistic teeth were taken as control. GCF
sampling was done with either using periopaper or
micropipette that were placed in the gingival sulcus.
An overview of the results obtained has been summa-
rized in Table 5.
Sample characteristics
Sample size
Of the 39 studies, the sample size varied, smallest being 7
subjects [40] to a maximum of 84 subjects [38]. The stud-
ies were categorized in four groups, with sample size up
to 10 (N = 15), 11 to 20 (N = 16), 21 to 30 (N = 5), and 31
and above (N = 3). Average sample size taken was 10 sub-
jects (N = 10).
Sex predilection
Information on sex of the subjects was mentioned in N
= 36 studies. One study (N = 1) included only male sub-
jects. Equal numbers of male and female subjects consti-
tuted the sample in ten studies (N = 10).
Age distribution
Age was expressed as either range or as mean with
standard deviation. There was no mention of age in
one (N = 1) study. Comparative evaluation of juvenile
and adults was reported in two studies (N = 2) and
adolescent vs. adults in one study (N = 1). Age groups
of male and females subjects were managed separately
in three studies (N = 3). Age group of up to 15 years
was considered in 19 (N = 19) studies and 15 years and
above was considered in 20 (N = 20) studies. One study
Table 1 Participant characteristics
Ref
no.








22 16 2 M, 14 F 18 to 24 y IL-1β Mx and Md C Md R or L C D Y Class I biMx Y NM Y NM
23 22 11 M, 11 F 14.4 + _1.1 y Leptin Mx C Contr C D N Mx 1st PM
Extr cs
Y Y Y Y
24 33 21 M, 12 F 10.8 to 30.9 y IL-1β, IL-1RA Mx C IP Md C/Aj T D y Mx 1st PM
Extr cs
NM NM NM NM
25 12 7 F, 5 M 13 to 17 y OPG Mx C Contr C D N Mx 1st PM
Extr cs
Y Y Y Y
26 9 5 M, 4 M 10 to 18 y IL-1β, βG 1st Mo, 1st
PM, CI
NM MP and MB N RME cs NM NM NM NM




SD: 11 to 18 y
LD: 19 to 27 y
IL-1β, −6, IL-8, TNF-α Mx 1st PM Ant T DB N Mx 2nd PM
Extr cs
Y Y Y Y
28 10 4 M, 6 F NM TNF-α C NM D N Mx 1st PM
Extr cs
Y Y Y Y
29 18 9 M, 9 F 16 to 19 y IL-1β, −TNF-α Mx C NM M and D N 1st PM Extr cs Y Y Y Y
30 30:15
J/15 A
J: 7 M, 9 F
A: 6 M, 9 F
J: 15.1 ± 2.8 y RANKL, OPG 1 Mx C Contr and
ant C
D N Mx 1st PM
Extr cs
Y Y Y Y
A: 31 ± 3.6 y
31 15 6 M, 9 F 15 to 19 y IL-2, IL-6, IL-8 Mx C NM M and D N 1st PM Extr cs Y Y Y Y
32 10 4 M, 6 F M −14.5 y RANKL, OPG Mx C Contr and
opposing C
D N Mx 1st PM
Extr cs
Y Y Y Y
F 15.4 y
33 18 10 M, 8 F 8.9 to 13.8 y IL-1β, SP, PGE2 1st Mx/Md M Ant L or
R 1st M
DB and DP N Crowding in 1
or both jaws
Y Y Y Y
34 9 3 M, 6 F M: 21.3 ± 2.8 y IL-1β, SP Mx C Contr C D N Mx 1st PM
Extr cs
Y Y Y Y
F: 23.1 ± 2.4 y
35 10 3 M, 7 F 10 y 5 m to 30 y
11 m
IL-1β, IL-1RA R and L Mx C Md. R C M and D Y Mx 1st PM
Extr cs
NM NM NM NM
36 10 NM 15 to 17 y IL-8 Mx and Md C NM M and D 1st PM Extr cs Y Y Y Y
37 10 2 M, 8 F 18.4 to 22.5 y IL-1β, PGE2 Mx C (E1),
Contr Mx C
(E2)
Ant Md C D N All 1st PM
Extr cs
Y Y Y Y
38 84 43 J (M) J: 11 ± 0.7 y PGE-2, IL-6, GMCSF Mx LI Contr LI M and DB N Labial tipping
reqd
Y Y Y Y
41 A (M) A: −24 ± 1.6 y
39 9 5 M, 4 F 10 to 18 y IL-1β βG 1st Mo, 1st
PM, CI
NM MP and MB N RME cs Y Y Y Y
40 7 2 M, 5 F 12 y 3 m to 16 y
3 m
IL-1β, IL-1RA, AI Mx C Md C M and D NM All 1st PM Extr Y NM Y NM
41 12 3 M, 9 F 14.4 ± 0.9 y TGF-β C Ant C/Contr C D NM All 1st PM
Extr
Y Y Y Y

















Table 1 Participant characteristics (Continued)
19 10 5 M, 5 F M: 24.6 ± 1.5 y F:
27.8 ± 3.9 y
IL-1β, PGE Mx LI, Mx
1st PM
Contr T MB N Buccal/labial
OTM
Y Y Y Y
43 50 23 M, 27 F 13 to 20 y IL-1β, TNF-α, NO Mx I, Mx C NM M and D NM Non Extr Y NM Y Y
44 10 5 M, 5 F 12 to 16 y RANKL, OPG 1st PM
(quad 1)
1st PM (quad 2) D NM 2nd Mx PM
Extr
Y NM Y NM
45 22 7 M, 15 F 19 to 29 y HSP70, RANKL Mx C Contr C NM Mx 1st PM Extr Y NM Y NM
46 12 6 M, 6 F 11 to 15 y MMP-8, IL-1β 1st M, CI, C NM M NM NM Y Y Y Y
47 21 NM 12 to 20 y GM-CSF, IF-ϒ, IL-1β, IL-2, IL-4, IL-5, IL-6,
IL-8, IL-10 and TNFα, MMP-9, TIMP-1
and 2, RANKL, OPG
Mx C 2nd M MB and DP NM Mx 1st PM Extr Y Y Y Y
48 10 5 M, 5 F 22 to 29 y RANK, OPG, OPN, TGF-β1 1st M Contr M Exp T: MB and
DB Cont T: MB
and ML
Y NM Y NM Y Y
49 14 3 M, 11 F 12 to 28 y MMP-3, MMP-9, MMP-13, MIP-1β, MCP-
1, RANTES
Mx C NM M and D NM Mx 1st PM Extr Y NM NM NM
50 18 8 M, 10 F 8.9 to 13.8 y IL-1β, SP, PGE2 1st M Contr M M and D NM Crowding in
Mx and Md
Y Y Y Y
51 10 NM 16.3 ± 2.5 y IL-1β Mx C Md C DB NM Class II, all
1st PM Extr
Y Y Y Y
52 16 8 M, 8 F 16.6 ± 2.4 y IL-2, IL-6, IL-8 Mx C Mx 2nd PM DB NM Mx 1st PM Extr Y Y Y Y
53 20 C: 3 M, 7 F
EX:5M,5 F
18 to 45 y CCL-2 (MCP1), CCL-3, CCL-5 (RANTES),
IL-8 (CXCL8), IL-1α, IL-1β, IL-6, TNF-α
Mx C Contr C DB Y Class II Div 1
Mal With 1st
PM Extr
Y Y Y Y
54 16 8 M, 8 F 16.6 ± 2.4 y TNF-α Mx C Mx 2nd PM DB NM Mx 1st PM Extr Y Y Y Y
55 17 9 M, 8 F 16 to 20 y TNF-α, IL-1β, IL-8 Mx C NM M and D NM All 1st PM Extr Y Y Y Y
56 10 5 M, 5 F 15 y ± 3 y 8 m IL-1β, IL-1RA Mx C Md C/Aj t D NM All 1st PM Extr NM NM NM NM
57 20 10 ado (3 M, 7 F),
10 A (4 M, 6 F)
Ado: 14.4 ± 1.43 y
A: −28.5 ± 7.83 y
RANKL, OPG, IL-1, IL-1RA, MMP-9 Mx I Md I Lab NM Non Extr,
3 to 6 mm
I crowding
N N Y N
58 24 HG-14
NHG-10
10 M, 14 FHG:
6 M, 8 F





NM MB and DB N Non extr cs Y NM Y Y
59 9 4 M, 5 F 17.5 to 18.9 y OPG, RANKL Mx C NM M and D NM All 4 Extr Y Y Y Y
Ref No. reference number, S sample, M/F male/female, med mediator, T tooth, sp specification, Rnd randomization, Mal malocclusion, HS hand searched, P PubMed, S Scopus, E Embase, N no, Y yes, Mx maxilla, Md
mandible, H history, Ls loss, Ging gingival, Inflm inflammation, PD probing depth, NM not mentioned, m month, d day, wk week, h hour, R right, L left, C canine, PM premolar, Mo molar, CI central incisor, Ant
antagonistic, Contr contralateral, IP interproximal, oppos opposing, Exp experimental tooth, Cont control tooth, Aj adjacent, E1 experimental site 1, E2 experimental site 2, Extr extraction, M mesial, D distal, Retr
retraction, y year, cs cases, IL interleukin, NO nitric oxide, RANKL receptor activator of NFкB ligand, β2-μG β2 microglobulin, TNF tumor necrosis factor, TGF transforming growth factor, EGF epidermal growth factor,
SP substance P, PGE prostaglandin, HSP heat shock protein, IFN Interferon, MMP matrix metalloproteinase, TIMP tissue inhibitor of metalloproteinases, MCP monocyte chemoattractant protein, MIP macrophage inflammatory
process, RANTES regulated on activation normal T cells expressed and secreted, GM-CSF granulocyte-macrophage colony-stimulating factor, reqd required, quad quadrant, OTM orthodontic tooth movement, Lab labial surface,

















Table 2 Study characteristics
Ref
no.
F T/O F Mech Mech/O appli React Tot Du No. of
obs
Time obs Bas Bas (same
as cont)
22. 50 and 150 g Cont F Retr- se Ni-Ti spg N 2 m 6 0, 1, 24 h, 1 wk, 1 m, 2 m 0 N
23. 250 g Intrrup F Retr- se E-chain NM 168 h 4 0, 1 h, 24 h, 168 h 0 N
24 4, 13, 26, 52,
or 78 kPa
Cont F Retr- se Vert loop act. with Ni-Ti spg N 84 d 9 to 10 0, 1, 3, ±7, 14, 28, 42, 56, 70, 84 d 0 N
25 150 g Cont F Retr- se Ni-Ti spg N 3 m 6 before act 0, after act 1 h, 24 h,
168 h, 1 m, 3 m
0 N
26 NM Interm F Mx expans Hyrax screw Y 81 d 10 0, 14, 25, 32, 33, 39, 46, 53, 60, 81 d 14 d Y
27 SD-NM
LD-50 cN
SD - intrrup F
LD - cont F
SD - space gaining
LD - Retr- se
SD-E - separt LD - Ni-Ti spg N SD - 24 h
LD - 4 m
SD - 2 LD - 5 SD - 0 h, 24 h LD - 0, T1, 1 m,
2 m, 3 m
0 N
28 HG - RDG-NM HG - cont F
RDG - heavy Intrrup F




1 wk 4 Before act (0), after act 1 h, 24 h,
1 wk
0 Y
29 Level-NS Cont F Level Retr- se 0.014” NiTi wireSentalloy
c.c. spg
N 6 m 21 d 7 Level - 0, 7 d, 21 d, 3 m After 6 m
Retr - 6 m (0), 7 d, 21 d
Level - 0
Retr - 6 m-0
Y
Retr - 150 g Cont F
30 250 g Intrrup F Retr- se E-chain NM 168 h 4 0, 1, 24, 168 h 0 N
31 Level-NS Cont F Level Retr- se 0.014” NiTi wireSentalloy
c.c. spg
NM 6 m 21 d 6 Level - 0, 7 d, 21 dAfter 6 m
Retr - 6 m (0), 7 d, 21 d
Level - 0
Retr - 6 m-0
Y
Retr - 150 g Cont F
32 250 g Intrrup F Retr- se E-chain N 7 d 4 0, 1, 24, 168 h 0 N
33 NM Intrrup F Space gaining E - separt N 14 d 5 −7 d, 0 d, 1 h, 1 d, 7 d 0 N
34 250 g Intrrup F Retr- se E-chain N 168 h 8 0, 1, 4, 8, 24, 72, 120, 168 h 0 N
35 60, 18, 120,
240 g
Cont F Retr- se Vert loop act. with Ni-Ti spg N 112 d 11 −28, −14, 0, 1, 3, 14, 28, 42, 56,
70, 84 d
0 N
36 Mx C - 115 g Cont F Retr- se Ricketts seg arch N 30 d 6 0, 1 h, 24 h, 6 d, 10 d, 30 d 0 Y
Md C - 90 g
37 E1: 100 g E1: Cont Retr E1: NiTi spg E1: N 3 wk 10 0, 1 h, 24 h, 1 wk, repeat twice 0 N
E2: NM E2: Intrrup E2: screw attached retractor E2: 2
38 70 cN Cont Tipping bu/la offset N 24 h 2 0, 24 h 0 N
39 NM Interm F Mx expans Hyrax screw Y 81 d 11 0, 14, 18, 25, 32, 33, 39, 46, 53,
60, 81 d
0 Y
40 13 to 4 kPa Cont Retr V loop act by spg N 84 d 9 0, 1, 3 d, 14 d intervals until 84 d 0 N
41 2 to 2.5 N Intrrup Retr E-chain N 7 d 4 0, 1, 24, 168 h 0 N
42 250 g Intrrup Retr E-chain N 7 d 4 0, 1, 24, 168 h 0 N
19 100 g Cont Labial tipping La offset in NiTi wire N 7 d 5 0, 1, 24, 48, 168 h 0 N
43 NM NM NM Alignment NM 6 m 3 0, 1 m, 6 m 0 N

















Table 2 Study characteristics (Continued)
45 130 g Intrrup Retr E-chain N 24 h 2 0, 24 h 0 N
46 NM NM NM Bracket placement N 3 m 4 0, 24 h, 1 wk, 3 m 0 Y
47 100 g Cont Retr NiTi c.c. spg N 42 d 4 −10 wk, 0, 4 h, 7 d, 42 d 0 N
48 NM Intrrup Space gain Elastic separt N 7 d 3 0, 24 h, 7 d 0 N
49 150 g Cont Retr V - loop and NiTi c.c. spg N 87 d 7 −7 d, 0, 1 h, 24 h, 14, 21, 80 d 0 Y
50 NM Intrrup Space gin Elastic separt N 14 d 6 −7 d, 0, 1 min, 1 h, 1 d, 7 d 0 N
51 120 g Cont Retr NiTi c.c. spg N 21 d 6 1 h, 24 h, 48 h, 168 h, 14 d, 21 d 1 h N
52 150 g Cont Retr Sentalloy c.c. spg N 3 m 7 0, 1, 24, 48 h, 7 d, 21 d, 3 m 0 N
53 100 g Cont F Retr- se Ni-Ti c.c. spg N 28 d 4 0, 1 d, 7 d, 28 d 0 Y
54 150 g Cont Retr Sentalloy c.c. spg N 3 m 7 0, 1, 24, 48 h, 7 d, 21 d, 3 m 0 N
55 NM Cont Alignment 0.014 NiTi wire N 7 d 8 0, 1, 2, 3, 4, 5, 6, 7 d 0 Y
56 13, 26,
52 kPa
Cont Retr V loop act by spg N 84 d 9 0, 1, 3 d, 14 d intervals until 84 d 0 N
57 NM Cont Alignment 0.014 - NiTi, 0.016 × 0.022
NiTi, 0.019 × 0.025 NiTi
N 20 wk 6 0, 3 wk, 6 wk, 12 wk, 2 wk 0 N
58 NM HG: band intrrup F
Bond - Cont F
NHG - Cont F
Level 0.014 - in NiTi wire 0.016 ×
0.022-in s.s.
N 70 wk HG: band-3 HG;
bond-2 NHG-2
HG: band - 18, 0, 52 wk HG: band -
18 wk
Y
HG: bond - 0, 52 wk Bond - 0 wk
NHG - 0, 52 wk NHG - 0 wk
59 200 g Cont Retr Sentalloy c.c. spg N 1 m 5 0,1 h, 24 h, 168 h, 1 m 0 Y
Ref No. reference number, F force, T/O type of, Mech mechanics, Mech/O mechanics of, appli appliance, React reactivation, Tot total, Du duration, N number, obs observation, Bas baseline, min minutes, g grams, Intrrup
interrupted, Cont continuous, interm intermittent, Retr retraction, se segmented, spg spring, E-chain elastomeric chain, NiTi nitinol, cont control, NM not mentioned, y year, d day, m month, h hour, Level leveling, separt

















Table 3 Oral hygiene regimen and assessment of gingival health










22 Chlorhex Twice NM NM Y Y
23 N NA Y Y Y At 0 and 168 h
24 NM NM Y Y Y Y
25 NM NA Y Y N N
26 Chlorhex Twice Y NM Y Y
27 Chlorhex Twice Y Y Y Y
28 NM NA NM NM Y NM
29 NM NA NM NM NM NM
30 NM NA Y Y Y Y
31 NM NA NM NM NM NM
32 NM NA Y Y Y Y
33 Chlorhex Twice Y Y Y Y
34 NM NA Y Y Y Y
35 Chlorhex Twice Y Y Y Y
36 NM NM Y Y Y Y
37 NM NM NM NM Y Y
38 NM NM Y Y NM NM
39 Chlorhex Twice Y NM Y Y
40 Chlorhex Twice Y Y Y Y
41 NM NM NM NM Y Y
42 NM NM NM NM Y Y
19 Chlorhex NM NM NM Y
43 NM NM Y Y Y Y
44 Chlorhex Twice Y Y Y Y
45 NM NM Y Y NM NM
46 NM NM Y Y (6 wk, 3 m) Y Y
47 NM NM NM NM Y Y
48 NM NM Y Y Y Y
49 Chlorhex Twice Y Y NM NM
50 NM NM Y N Y Y
51 NM NM NM NM NM NM
52 NM NM Y Y Y NM
53 NM NM Y Y Y NM
54 NM NM Y Y Y NM
55 NM NM NM NM NM NM
56 Chlorhex Twice Y Y Y Y
57 NM Y NM NM NM
58 NM NA Y NM Y Y
59 NM Y Y Y Y
Ref No. reference number, Mu mouth, wsh wash, Freq/O frequency of, d day, prophy prophylaxis, t/t treatment, obser observation, pt point, Asses assessment, ging
gingival, perio periodontal, inflam inflammation, chlorhex chlorhexidine, Y yes, NM not mentioned, N no, h hour.
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Table 4 GCF characteristics
Ref
no.

















22 NM NM NM D 1 mm 2 90 s PP 30 s −80°C PT8000 ELISA pg/mg
23 Y NM NM D 1 mm 4 60 s PP 30 s −80°C PT8000 ELISA pg/ml
24 NM NM NM D NM 2 NM NM NM NM NM ELISA NM
25 NM NM NM D 1 mm N NA PP 30 s −80°C PT8000 ELISA pg/μl
26 NM Y Y M NM N NA PP 30 s NM PT6000 ELISA pg/30 s
27 NM NM NM DB 1 mm N NA PP 30 s −20°C PT8000 MB-IA pg/μl
28 Y NM NM D 1 mm 4 60 s PP 30 s −80°C Elec scale ELISA pg/μl
29 Y NM NM M and D 1 mm N NA PP 30 s −20°C PT8000 IA pg
30 NM NM NM D 1 mm 2 60 s PP 60 s −30°C PT8000 ELISA pg/μl
31 Y NM NM M and D NM N NA PP 30 s −20°C PT8000 IA pg
32 NM NM NM D 1 mm 1 60 s PP 60 s −30°C PT8000 ELISA pg/μl
33 NM NM NM DB and DP 1 mm NM NA DuFM 20 s −70°C NM ELISA pg/20-s samp
34 NM NM NM D 1 mm 2 NM PP 60 s −30°C PT8000 ELISA pg/μg
35 NM NM NM M and D 1 mm 1 60 s PP 30 s −70°C NM ELISA mg/l - tot prot,
IL-1-ng/g IL-1RA- μg/g
36 NM NM NM M and D 1 mm 1 60 s PP 30 s −70°C Elect scale ELISA pg/ml
37 Y Y Y D 1 mm 4 1 min PP 30 s −70°C NM ELISA pg/μg
38 NM Y NM MB and DB 1 mm N N PP 30 s −80°C PT6000 RIA pg/μl
39 NM Y Y M NM N NA PP 30 s NM PT6000 ELISA pg/30-s GCF
40 NM NM NM M and D 1 mm 1 1 min PP 30 s −70°C NM ELISA Tot prot - mg/l, IL-1β
(ng/g), IL-1RA (μg/g)
41 NM NM NM D 1 mm 1 1 min PP 30 s −30°C PT ELISA, EP,
WB
pg/μg
42 NM NM NM D 1 mm 1 1 min PP 30 s −30°C PT ELISA pg/μg
19 Y Y y MB 1 mm N N PP 30 s −80°C PT6000 RIA pg
43 NM NM NM M and D NM NM NM PP 30 s NM PT8000 ELISA NM
44 NM NM NM D NM N N PP 30 s −80°C PT8000 ELISA pg/μl
45 NM NM NM D 2 mm 1 2 min PP 1 min −20°C NM ELISA, WB,
SDS-PAGE
NM
46 NM NM NM M NM N N FP 3 min −30°C NM ELISA IL-1β; pg/ml,
MMP-8: ng/ml
47 NM NM NM MB and DP NM N N PP 30 s NM PT8000 LMAT pg/ml
48 NM NM NM ExpT: MB and DB
Cont T: MB and ML
1 mm N N PP 30 s NM PT8000 ELISA Cyt conc - pg/μlTot
prot (pg)
49 NM NM NM M and D 1 mm N N PP NM −80°C PT8000 MB-IA pg/site
50 NM NM NM MB and DB 1 mm N N FM 20 s −70°C NM ELISA pg/20 s
51 Y Y Y DB NM N N FP 3 min −70°C NM ELISA pg/μl
52 Y NM NM DB NM 1 1 min PP 30 s −20°C PT8000 ELISA pg/μl
53 Y NM NM DB 1 mm 0 NA FP 10 s NM PT8000 CPA pg/μl
54 Y NM NM DB NM 1 1 min PP 30 s −20°C PT8000 IA pg/μl
55 Y NM NM NM 1 mm N N PP 30 s −20°C PT8000 IA pg
56 NM NM NM D 1 mm 1 1 min PP 30 s −70°C NM ELISA Tot prot - mg/l, IL-1β
(ng/g), IL-1RA (μg/g)
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Table 4 GCF characteristics (Continued)
57 NM NM NM DL 1 mm N N PP 30 s −80°C NM QAK pg/ml
58 NM NM NM MB and DB NM 2 NA PP 30 s −70°C PT6000 BHCA pg/ml
59 NM NM NM M and D 1 mm 1 1 min PP 30 s −70°C Precisa 62
A
ELISA pmol/l
Ref No. reference number, Humd humidity, sp specification, Inser insertion, MB mesio-buccal, ML mesio-lingual, DP disto-palatal sites, DB disto-buccal sites, M mesial, D distal,
NM not mentioned, N no, Y yes, PP periopaper, PT periotron, FP filter paper strips, FM Durapore filter membrane, WB Western blot, ELISA enzyme linked immune sorbent
assay, SDS-PAGE sodium-dodecyl sulfate polyacrylamide gel electrophoresis, RIA radio-IA, I/O interval of, Meth/Omethod of, coll collection, meas measurement, Du/O duration
of, Temp temperature, sto storage, Anal analysis, Prot protein, conc concentration, pg picogram,mg microgram, ml milliliter, μl microliter, GCF gingival crevicular fluid, tot total,
g gram, ng nanogram, s seconds,minminutes, °C degree Celsius, elect electronic, IA immunoassay, EP electrophoresis, sP spectrophotometry, Ar array, A assay, MB multiplex
bead, LMAT Luminex multianalyte technology, BHCA Bio-Plex human cytokine assay, CPA custom protein array, QAK Quantibody Ar kit, DuFM Durapore filter membrane.
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Mediators of orthodontic tooth movement
Cytokines, receptors and their antagonists included in the
review have been listed in Table 1. The cytokines have
been studied singularly or in combination with other me-
diators. The most often studied cytokines in tooth move-
ment are IL-1β (N = 21), TNF-α (N = 10), IL-8 (N = 8),
IL-6 (N = 8), IL-2 (N=4), IL-4, IL-10 (N = 2), IL-1, IL-5,
IL-1α (N = 1), OPN (N= 1), and RANKL (N= 7).
Receptors and their antagonists have been studied in the
frequency of OPG (N = 8), IL 1RA (N= 5), and RANK (N
= 1). Chemokines have been studied in the order of mono-
cyte chemoattractant protein (MCP)-1 (N = 3), RANTES
(N= 2), and IP-10 (N = 1). Studies related to growth factors
were GMCSF (N = 3), TGF-β (N = 2), and IFN-γ (N = 2)
and there was only one (N = 1) study on Leptin.
Time period and observation intervals
The total time duration for studies exhibited large variation
from as low as 24 h to as high as 70 weeks. Studies were
performed for a duration of 24 h (N = 3), 1 week (N = 10),
2 weeks (N = 2), 3 weeks (N = 2), approximately 1 month
(N= 5), 2 months (N= 1), approximately 3 months (N= 10),
4 months (N = 2), 5 months (N = 1), and 6 months and
above (N = 4).
GCF collection was done at multiple observation times
ranging from a maximum of 11 times (N = 2) to minimum
at 2 times (N = 4). Nine studies (N = 9) used 4 observation
times; eight (N = 8) studies used 6 observation times; four
(N = 4) studies used 2, 5, and 7 observation times; three
(N = 3) studies used 3, 9, and 10 observation times;
and two (N = 2) studies used 8 observation times.
Thirty-seven (N = 37) studies took observation point be-
fore activation as ‘zero’ or baseline. The protocol followed
for GCF collection was 0, 1 h, 24 h, and 7 days (N = 14)
and of 0, 1 h, and 24 h (N = 15). An additional observation
point at 14 days (N = 7) and 21 days (N = 6) was also
considered. An internal control (baseline levels) was con-
sidered in N = 12 studies while other studies (N = 27) took
an external control that was either contralateral or antag-
onistic tooth or tooth other than experimental tooth.Study design
Mechanics of force application
Twenty-seven studies considered retraction of canine
(N = 27) which included NiTi coil spring (N = 18), vertical
loop (N = 5), screw-based retractors (N = 3), and segmental
mechanics (N = 14). Other methods of force applications
were separators (N = 4), expansion with hyrax screw
(N = 2), labial tipping with offsets in wire (N = 2),
bracket placement (N = 1), and leveling of arches (N = 5).
Type of force application
Twenty-six studies (N = 26) used continuous force and 12
(N= 12) employed interrupted force. There was no mention
of type of force in two (N = 2) studies. Four studies used
continuous and interrupted force on different index
teeth (N = 4).
Levels of force
Twenty-eight studies (N = 28) mentioned levels of force
applied while eleven studies (N = 11) have no mention of
it. One-hundred fifty-gram force was used in eight stud-
ies (N = 8), followed by 250 g (N = 5) and 100 g (N = 4).
One study (N = 1) each employed 50, 120, 130, and 200 g;
70 cN; and 2 to 2.5 N of force. A range of force was
applied from 4 to 13 kPa (N = 1), 90 to 115 g (N = 1), and
4, 13, 26, 52, or 78 kPa in N = 2 studies. Force reactivation
was considered in three (N = 3) studies to compare con-
tinuous and interrupted force.
Oral hygiene regimen and gingival health assessment
Professional oral prophylaxis was performed before treat-
ment (N = 28) and at every observation point (N = 23) but
was not mentioned in the remaining studies. Oral hygiene
regimen with recommendation of chlorhexidine mouth-
wash was mentioned in 11 studies (N = 11) and its fre-
quency (N = 10) studies. Indices for assessment of gingival
and periodontal health were employed before the treatment
(N = 30) and at every observation point in N= 24 studies.
GCF characteristics
The GCF samples were collected at a particular time of the
day (N= 11), preferably 9 AM to 12 PM and early morning
(N = 2). Twenty-eight (N = 28) studies had no mention of
Table 5 Result characteristics
Ref
no.
Mediators Stats analy appld Confd Drop
outs
Up/down reg Pk Sec outcm r Stat sign readings
22. IL-1β ANOVA and Friedman
and paired t
Y NM Inc 24 h, 2 m 1. Mean tot prot conc -
12 mg/ml
C mov with less pain and inflam
with 50 g than with 150 g of F
Inc at 24 h and 2 m in 150 g F compd
to cont
2. VAS score of 150 g >
50 g at 24 h
23. Leptin Wilcoxon, Friedman NM NM Dec 168 h NM NM b/w bas and 168 h in exp T
24 IL-1β,
IL-1RA
ANCOVA Y Y Fluct NM For same stress and grw status,
max diff in speed were 4.2:1
for 13 kPa in growers and 4.8:1
for 26 kPa in Nn-growers
Higher speeds of T move sign
assoc with gen type 2 at IL-1β
(+3,954), higher AI, and lower
IL-1RA in GCF
NM
25 OPG Shapiro Wilk’s
Normality, Wilcoxon,
Friedman, Z
NM NM Dec NM NM NM Dec at 1 h, 24 h, 168 h, 1 m, 3 m
compd with bas
26 IL-1β, βG 1-tailed paired Student t Y NM Inc M-010
PM-07 CI-08
βG sign inc for M - 07 to 010
PM-07,08,010 CI - 06, 07, 010
and dec at O2 for M, PM, CI
Stronger F cause higher levels
of both IL-1β and βG
IL-1β sign inc for M - O5 to O10
for PM-O6 to 010. For CI - 04, 06, 07,





Y NM Inc SD - 24 h
LD - T1
NM NM In SD IL-1β, IL-8, TNF-α inc, In LD
inc of IL-8 at T1
28 TNF-α Intergrp - Mann-Whitney
UIntragrp - Wilcoxon
signed rank
NM NM Inc 24 h PI, PD, BOP sign higher in HG
GCF vol at 1 h and 24 h in
the RDG > HG
NM HG - a stat sign dec at 1 wk compd to 24 h.
RDG - inc at 1 h stat sign compd to
initial value. Inc in RDG at 1 h >HG
29 IL-1β,-TNF-α 1-way paired t,
Mann-Whitney U
NM NM Inc 7 d, 21 d GCF vol inc on 7 d and 21 d
of level and retr
NM TNF –α diff b/w 3 m (level) and
6 m (bf retr)
30 RANKL, OPG 3-way analysis of variance
Tukey’s honest sign diff
Y NM RANKL- Inc
OPG- Dec
24 h avg amt of TM for J > A after
168 h mean vol of GCF in A
sign lower than J
GCF vol correl with inflam state RANKL at 24 h - sign inc levels both
in J & A. RANKL and OPG in A < J
OPG at 24 h sign dec levels both in J & A.
RANKL/OPG for exp T sign >
cont after 24 h RANKL/OPG in A < J
31 IL-2, 6, 8 1-way paired t
Mann-Whitney U
NM NM IL-2-inc IL-2 - 7 d, 21 d
of level IL-8 -
7 d of level
and 7 d, 21 d
of retr
GCF vol greater on 7 d and
21 d of level and retr
NM IL-8 stat sign dec on 7 d of level
IL-6-N change
IL-8-dec
32 RANKL, OPG Mann-Whitney U NM NM RANKL - inc
OPG - dec
24 h In vitro compres F for 3, 6, 9, 12,
24, 48 h, RANKL was sign inc in
stress (+) grp
N sign diff in mean vol of GCF
at 24 h b/w exp T and cont T
Mean RANKL values after 24 h in
Exp > cont-mean OPG values after
24 h in Exp < cont
33 IL-1β, SP,
PGE2
Paired t multiple linear
regression analysis
Y NM Inc 1 d VAS inc sign 1 h and 24 h after
insert of sepr and returned to bas
after 7 d SP and PGE2 sign higher
at 1 d and 7 d
NM IL-1β of exp > cont at 1 h, 1 d, 7 d
34 SP, IL-1β Mann-Whitney U
Spearman’s signed rank
NM NM Inc NM Avg amt of TM was 1.5 ± 0.4 mm
over 168 h-N sign diff in tot prot
level at any of exp time periods
mean SP levels inc after 8, 24,
and 72 h in Exp
N sign diff in mean GCF vol
b/w exp and cont T
mean IL-1β levels inc after 8, 24, and

















Table 5 Result characteristics (Continued)
35 IL-1β, IL-1RA ANCOVA Y NM NM 3 d Inc lag phase with Mx C moved
by 4, 13, and 26 kPa.By 52 kPa,
distinct lag phase at 3 d, 14 d
Vt vs avg AI in GCF from D sites
of Mx C showed a + ve
relationship (R2 = 0.44)
mean AI for C moved with 52 kPa sign >
all other mean AIs
36 IL-8 Mann-Whitney U
Wilcoxon




GCF vol greater at tension and
pressure sites at 24 h and 30 d
NM IL-8 at both sites inc at 1 h of F. B/w 24
hand 6 d, inc at tension site. IL-8 inc
among grps b/w 0 & 1 h stats sign
37 IL-1β, PGE2 Intra-grp: ANOVA
Intergrp: 1-way ANOVA
NM NM Inc 24 h PGE2 inc at 24 h > BS in CF and
IF. PGE2 inc in CF and IF at 24 h >
cont In CF,PGE2 > cont at 168 h,
then fall. In IF, PGE2 remain high
for a wk.
NM IL-1β inc at 24 h > BS, max at 24 h
after 1st act in IF.
In IF, IL-1β inc 24 h after 1st reactivn >
cont




independent t (J and A)
NM NM Inc 24 h Median GCF vol. in J > A. In J
and A PGE2 inc at 24 h > BS
NM InJ, IL-6, GMCSF inc at 24 h > BS
39 IL-1β, βG 1-tailed paired Student t Y NM Inc IL-1β - 81 d
βG - 46 d
βG - significantly dec 14 d after
prophy. Exp > cont at 46 d
NM IL-1β significantly dec 14 d after prophy.






NM NM Inc 3 d C retr at 1.27 and 0.87 mm/m
for 13 and 4 kPa of stress, resp
+ve corr of velocity and AI
from D >M.
IL-1β at M > Cont (13 kPa) IL-1RA at
D >M and Cont (4 and 13 kPa)Tot
prot at M and D > Cont (4 and 13 kPa)




Student’s t Y NM Inc 24 h β-2 MG inc at 24 h > BS or 1 h NM Intra-grp in Exp: IL-1β inc at 24 h > bas,
IL-6 inc at 24 h > bas or 168 h, TNF-α inc at
24 h > bas or 168 h, EGF inc at 24 h > bas
β-2 MG in exp at 24 h > ant cont Intergrp btw cont and exp: IL-1β inc in
exp > cont at 24 h, mean IL-6 in exp >
ant cont, TNF-α in exp at 24 h > ant
cont, EGF in exp at 24 h > ant cont
19 IL-1β, PGE 2-way analy of
variancepaired t
NM NM Inc 24 h PGE inc in exp > cont at 24 h, 48 h NM IL-1β inc in exp > cont at 1 h, 24 h






Y NM Inc 6 m PI, GI, PD inc at 1 m > BS,
6 m > BS
NM IL-1β inc at 6 m > bas
44 RANKL, OPG Repeated measures
ANOVA
NM NM Inc 48 h PM retr −3.73 ± 1.08 mm
(laser grp) and 2.71 ± 0.9 mm
(Cont grp) Max mean retr v(t)
btw 0 and 48 h. Pain intensity
pk at 48 h.
NM RANKL - inc at 48 h > bas
RANKL/OPG - inc at 48 h > bas
45 RANKL, HSP70, ANOVA post hoc
Fisher’s LSD
Y NM Inc 24 h Amylase activity in saliva inc
at 24 h at exp > cont
NM RANKL inc in 24 h > cont








Y NM Inc 4 h +ve corr of GCF vol and plaque
index at 0 at(t), (comp)
+ve corr of TNF-α, IL-1β, IL-8,
GM-CSF MMP-9 and TIMP levels
to speed of OTM at 4 h in Exp corr
of IL-1β, IL-8, TNF-α inc to
Exp - IL-1β, IL-8, TNFα inc from 4 h
to 42 d. RANKL - inc after 42 d
Exp - TIMP 1 and 2 inc at 4 h, 7





















plaque-induced inflam at 0
at (comp).
Compr-MMP −9 inc at 4 h and 7
d. TIMP-1 inc at 4 h and TIMP-2
at 7 d.
Exp > cont: MMP-9 inc at 0, 4 h







Y NM Inc 7 d NM NM RANK - inc in 7 d in exp, compres >
cont OPG - cont > compres site at 24 h.




Friedman, Mann-Whitney Y NM NM NM MMPs inc at 1 h, dec at 24 h.
GCF vol at (comp) > (t) at 21 d
NM NM
50 IL-1β, SP, PGE2 SPSS 13.0 paired t-test
Wilcoxon paired
signed rank
NM NM Inc 1 d Exp > Cont: NM Exp > Cont:
At D, SP inc at 1 d, 7 d At M, IL-1β inc at 1 min, 1 h, 1 d, 7 d.
At D, PGE2 inc at 1 min, 1 h,
1 d, 7 d.
At D, IL-1β at 1 h, 1 d, 7 d.
At M, PGE2, SP, inc at 1 min,
1 h, 1 d, 7 d > BS.
Exp > bas: At M, IL-1β inc at 1 min,
1 h, 1 d, 7 d. At D, IL-1β inc
At D, SP, PGE2 inc at 1 d, 7 d > BS. at 1 h, 1 d, 7 d.
51 IL-1β Wilcoxon signed-rank
Mann-Whitney U
NM NM Inc 24 h IL-1β at 24 h, 48 h at exp> implant NM IL-1β inc at 24, 48 h > bas IL-1β dec
after 24 h, at 48 h, 168 h, 14 d, 21 d.
52 IL-2, IL-6, IL-8 1-way ANOVA ( interG)
Dunnett’s t Tukey’s
NM NM Inc 24 h IL-8 inc at 24 h, 48 h in MS grp NM IL-2 inc at 24 h > bas






ANOVA Tukey’s post hoc
paired and unpaired t
Y NM Inc 24 h MOPs inc the rate of C retr by
2.3-fold compd to cont and
contr C - VAS sign at 24 h for
Exp and Con
MOPs sign inc cyt and
chemokine expression
All cyt and chemo inc in both Cont
and Exp at 24 h IL-1 inc also at 28 d
54 TNF-α Paired t (intra G)1-way
ANOVA (interG) Dunnett’s
t Tukey’s
NM NM Inc 24 h NM NM TNF-α inc at 24 h
55 TNF-α, IL-1β, IL-8 1-way ANOVA Paired
student t
NM NM TNF-α, IL-1β,
IL-8 inc in 1
to 2 d of level
1 d GCF vol inc in 1 to 3 d of leveling NM TNF-α, IL-1β, IL-8 inc in 1 to 2 d of level
56 IL-1β, IL-1RA, AI Least square Regression
Pearson product-moment
Correl coefficient
NM NM AI = 1, then
v(t) is not zero
NM C retr at day 84 for 13, 26, 52
kPa were 4.14 ± 0.19, 6.36 ± 1.32,
5.66 ± 1.38 mm resp
v(t) affected by AI in GCF,
stress and IL-1 gene cluster
Faster v(t) seen in 26 kPa, higher GCF
and allele 1 homozygosity









A - 6 wk NM NM IL-1RA in adults exp > cont at 3 wk. Dec in
ratio of (IL-1/[IL-1 + IL-1RA]). Inc in ratio of
RANKL to OPG (RANKL/[RANKL + OPG]).
RANKL to OPG inc at 6 wk in ado, at 3 wk
in A, OPG in ado at Exp < cont at 6 wk
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Stepwise regression NM NM NM NM NM IL-6 levels at bas predictive of
GCF flows after 1 y of ortho t/t
No sign change
59 OPG, RANKL 2-way ANOVA.A
Bonferroni f
NM NM OPG inc in M,
dec in D at 1 h
1 h NM NM OPG inc on M, dec in D at 1 h
Ref No. reference number, Stats statistically, analy analysis, appld applied, Confd confounders, reg regulation, Pk peak, Sec secondary, outcm outcome, correl correlation, sign significant, Y yes, N no, NM not mentioned,
inc increase, dec decrease, fluct fluctuated, h hour, m month, tot total, prot protein, conc concentration, mg milligram, ml milliliter, g gram, > greater than, < less than, VAS visual analog scale, C canine, mov movement,
b/w between, CF continuous force, IF interrupted force, and and, F force, Assoc associated, gen genetic, GCF gingival crevicular fluid, compd compared, bas baseline, IL interleukin, βG beta glucoronidase, TNF-α tumor
necrosis factor alpha, SD short duration, LD long duration, Diff difference, vol volume, retr retraction, correl correlation, inflam inflammation, Avg average, cyt cytokine, chemo chemokine, knwn known, MOPs micro-
osteoperforations, PI plaque index, BOP bleeding on probing, exp experimental, cont control, Exp experimental tooth, ant antagonistic, Avg average, Mx maxilla, contr contralateral, differen differentiation, sepr separator,
grp group, compres compression, kPa kilopascal, max maximum, grw growth, T tooth, Oc osteoclast, RDG rapid canine distalization group, HG hybrid reactor group. v(t) velocity of tooth movement, M mesial, D distal,
level leveling, retr retraction.
CSFs colony-stimulating factors, IFNs interferons, MCSF macrophage colony-stimulating factor, SP substance P, IL-1β interleukin-1 beta, TNF-α tumor necrosis factor-alpha, TGF β transforming growth factor-beta, OPG
osteoprotegerin, OPN osteopontin, RANKL receptor activator of nuclear factor kappa-B ligand, RANK receptor activator of nuclear factor kappa-B, GM-CSF granulocyte-macrophage colony-stimulating factor, βG beta
glucuronidase, PGE2 prostaglandin E2, IL-1RA interleukin receptor antagonist, MCP monocyte chemoattractant protein, MMP matrix metalloproteinases, MIP macrophage inflammatory protein, TIMP tissue inhibitor of

















Kapoor et al. Progress in Orthodontics 2014, 15:65 Page 16 of 21
http://www.progressinorthodontics.com/content/15/1/65time for GCF collection. The room temperature conditions
were considered in six (N = 6) studies and humidity in five
(N = 5) studies.
The sites for GCF sample collection were either mesial
(N = 5) or distal (N = 21) or both mesial and distal (N = 12).
GCF collection was done by periopaper (N = 33) studies,
filter paper (N = 3), or filter membrane (N = 2). One study
(N = 1) did not mention the technique by which GCF was
collected.
Depth of insertion of paper for GCF collection was
mentioned in 27 studies with the most common practice
being a 1-mm depth (N = 26). One study used 2-mm
depth of insertion. Duration of GCF collection was spe-
cified to be 30 s in most studies (N = 29) followed by 60
s (N = 4), 3 min (N = 1), 10 s (N = 1), and 20 s (N = 1).
Repeated measurements were considered in 19 studies
(N = 19) with collection repeated once in N = 11 studies,
twice in N = 5 studies, and 3 times in N = 3 studies. The
interval was 60 s (N = 14), 90 s (N = 1), and 120 s (N = 1).
The samples were stored at −20°C (N = 7), −30°C
(N = 6), −70°C (N = 10), and −80°C (N = 9). The GCF
from periopaper was retrieved by Periotron (PT)8000 (N =
18), PT6000 (N = 5), PT (N = 2), or electronic scale (N = 3)
and was not mentioned in some studies (N = 11). Mediators
were analyzed by ELISA (N= 27), immunoassay (IA) (N =
8), Luminex multianalyte technology (LMAT) (N = 1), Bio-
Plex human cytokine assay (BHCA) (N = 1), custom protein
array (CPA) (N = 1), or Quantibody Ar kit (QAK) (N = 1).
Protein concentration in GCF was measured in pg/μl (N =
12), pg (N = 5), pg/mg (N = 1), pg/ml (N = 5), pg/mg (N =
1), pg/μg (N = 30), pg/30 s (N = 2), pg/20 s (N = 1), and pg/
site (N = 1) and was not mentioned in N= 3 studies.
The total number of studies included in this review
are 39. However in the result section, some of the vari-
ables showing number of studies may be more than 39,
as few parameters have been divided into subgroups that
have been considered as a separate variable.
Mediator levels in GCF
Interleukins Twenty-one studies on IL-1β were evaluated.
Of these, ten studies (N= 10) reported that the peak levels of
IL-1β were attained at 24 h [19,22,27,33,37,42,50,51,53,54].
The peak levels in other studies have also been reported at
4 h [47], 3 days [35,40], 7 days, 21 days [29], 2 months
[22], around 3 months [39,46], and 6 months [43]. One
study mentioned peak for different teeth at different ob-
servation points [26] that resulted in peak for molars at 67
days, for premolars at 32 days and for central incisors at
39 days. Another study did not mention peak but fluctu-
ation in IL-1β levels on application of different stresses of
teeth that were correlated with velocity [24].
One study mentioned IL-1β levels on application of 150-g
force to be twice that on application of 50-g force at 24 h
and 2 months [22]. Studies have shown decrease in levels ofIL-1β, 14 days after prophylaxis, followed by an increase
upon activation of orthodontic appliance (N= 2) [26,39].
Forces of short duration show an increase in IL-1β at 7 and
21 days [29]. Levels of IL-1β in experiment teeth were shown
to be greater than control teeth at 1 h [19,33], 4 h [47], 8 h
[34], 24 h [19,33,34,42],72 h [34], 7 days [33], 25 days
[26,39], 32 days [26,39], 33 days [39], 39 days [26,39], 42 days
[47], 46 days [26,39], 67 days [26,39], and 81 days [26,39].
A comparison of continuous and interrupted force was
evident in one study [37] where it was shown that IL-1β
levels in continuous force is greater than baseline at
24 h while in interrupted force, levels were greatest at
first reactivation.
Difference in IL-1β levels according to site specification
was mentioned in one study [40] where levels at distal site
of tooth retraction were greater than mesial site at both 4
and 13 kPa of force application. Placement of elastic sepa-
rators in molars led to an increase in levels at 1 min, 1 h,
24 h, and 7 days [50] at mesial site while at distal site, in-
crease was seen at 1 h, 24 h, and 7 days [50].
An upregulation in IL-1β levels from baseline levels was
evident at 1 min [50], 1 h [50], 24 h [19,37,42,51,54], 48 h
[51], 7 days [50], 3 months [46], and 6 months [43] and
downregulation was seen in 48 h, 168 h, 14 days, and 21
days [51].
For IL-6, the levels were found to increase at 24 h
[38,53] when continuous forces were applied for retrac-
tion or tipping.
IL-8 also increased on application of continuous force
for retraction at 1 h [36,52] both on tension and pressure
sites [36] and also at 4 h [47], 24 h, and 48 h [52]. Place-
ment of separators led to an increase in levels at 24 h [27].
Fall in levels was observed at 7 days of leveling and an in-
crease was seen at 7 days, 21 days of retraction [31].
TNF-α Application of interrupted force witnessed an in-
crease in levels at 1 h [28] and 24 h [27,42] while con-
tinuous force application led to increase in levels at 24 h
[53,54] or 4 h to 42 days [47]. There was a decrease in
levels in 1 week on continuous force retraction by hybrid
retractor (HG) [28]. TNF-α levels also increased at 1 day
[54], at 3 months [29] of leveling, and at 6 months, just
before retraction [29]. A comparison of continuous force
application by hybrid retractor (HG) by HG to interrupted
force by rapid canine distalizer (RDG) showed higher
values at 1 h in RDG group compared to HG [28].
Levels of receptor and their antagonists in GCF
RANKL
RANKL showed an increase in levels at 24 h [30,32,45]
greater than control as well as baseline with specific
mention of levels in juveniles and adults [30,32]. Two
studies (N = 2) mentioned increase in levels greater than
baseline, one at 48 h [44] and other at 42 days [47] at
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greater than baseline. Correlation with age was estab-
lished with levels in adults being less than juveniles
[30,32], an increase in RANKL/OPG ratio in 6 weeks in
adolescents [57].
IL-1RA
Lower value IL-1RA was shown to be associated with
higher velocity of tooth movement (Vt) [24]. It was also
a determinant of activity index (AI) that is ratio of con-
centrations of IL-1β and IL-1RA in GCF, known to correl-
ate with Vt [24,35,40,56]. One study mentioned distinction
of site where levels at distal site of retraction were greater
than mesial and control on application of 4 and 13 kPa
force [40]. A comparison between levels in adults and
adolescents revealed a decrease in ratio of IL1/(IL1 +
IL-1RA) in 3 weeks [57].
OPG
The levels were decreased in experimental teeth at 1 h [25],
24 h [25,30,48], 168 h [25], 1 month [25], and 3 months
[25] than baseline levels. A distinction of age-specified
levels of OPG as well as ratio of RANKL/OPG was found
to be lower in adults than in juveniles [30]. The levels of
OPG in experimental teeth were found to be lower in ado-
lescents in 6 weeks compared to control teeth [57]. Its
values were less in adolescents in 6 weeks [57]. Site speci-
fication determined levels to increase on tension site (me-
sial) and to decrease on compression site (distal) [59].
Chemokines [CCL-2 (MCP1), CCL-3, CCL-5 (RANTES),
IL-8 (CXCL8)] showed an increase in both experimental
and control teeth at 24 h of force application [53]. Levels
of IL-8 were increased when force was applied for a short
duration in separator placement [27], or longer duration
in initial alignment [27], 1 to 2 days of leveling [54], in-
crease from 4 h to 42 days [47], at 1 h, 24 h, and 48 h [52]
when continuous forces were applied for retraction. Levels
also showed a decrease in 7 days of leveling [31]. A differ-
ence in levels was observed with distinction of site, with
levels increased at both mesial and distal sites at 1 h of
force application, between 24 h and 6 days at tension site
and a statistically significant increase at tension site
greater than compression site [36]. Two studies (N = 2) on
chemokines did not reveal any significant findings [49,58].
Discussion
This systematic review was primarily aimed to conjure
substantial evidence regarding the cytokine, chemokine,
receptor and their antagonist (RANK, RANKL, OPG)
levels in GCF consequent to application of orthodontic
force. The literature revealed heterogeneity in study
designs pertaining to participant characteristics, force
application, levels of force, GCF collection methods
and collection protocol, storage, and oral hygienemaintenance regimen. To draw logical conclusions each
of the variables was tabulated and analyzed separately.
Associations of change in levels of mediators were estab-
lished with mechanics of applied orthodontic force,
amount of force, force reactivations, differentiation in
levels between tension and compression sites, age groups
(juveniles and adults, growers and non-growers), and
velocity of tooth movement (Vt).
The altering levels, rise, and fall of the mediators in
GCF are suggestive of underlying intricate biological re-
modeling processes in bone and periodontal tissues that
eventually leads to OTM. The forces employed for OTM
or midpalatal expansion led to an initial increase in
levels of bone-resorptive mediators as well as associated
receptors namely IL-1β, IL-8, RANKL, and TNF-α as
early as 1 min [50] or 1 h [28] and attained peak in 24 h
[19,22,27,30-33,37,42,45,50,51,53,54]. These mediators
slowly decrease to baseline in subsequent observation
points at 48 h, 168 h, 14 days, and 21 days [28,31,51]. On
the contrary, bone-forming mediators like OPG show an
immediate decrease in levels on application of orthodontic
forces at 1 h on distal site of retraction [25,59], at 24 h
[25,30,32,48]. The role of RANK, RANKL, and OPG sys-
tem in governing osteoclastogenesis has also been cor-
roborated in animal studies [61,62] and in vitro studies
[63-66] on periodontal ligament cells. When compressive
orthodontic force is applied, upregulation of RANKL oc-
curs which leads to stimulation of PGE2 pathway and fi-
nally, osteoclastic activity is initiated which results in bone
resorption [65,66]. OPG, a RANKL decoy receptor generated
by osteoblastic cells and cells of the periodontal ligament,
binds to RANKL and inhibits RANK/RANKL interaction
that is the mainstay of osteoclastogenesis [67].
Besides these receptors, other factors that are directly
or indirectly responsible for differentiation, survival, and
activity of osteoclasts are cytokines (IL-1β, TNFα, IL-6)
and chemokines (CCL2, CCL3, CCL5, CCL7, CCL9, IL-8)
[68,69]. The literature search in the present review found
an increase in levels of these mediators in GCF on ortho-
dontic force application. Evidence proves that mechanical
stress induces acute inflammatory changes that alter the
microvascular environment, with studies supporting local
release of mediators IL-1β, TNF-α, and expression of che-
mokines that ultimately promotes leukocyte adhesion and
migration [70]. IL-1β (N = 21) and TNF-α (N = 10) are the
most researched cytokines, supporting their role in the in-
flammatory changes associated with orthodontic tooth
movement (OTM). Variation in mediator levels with type
of force and force reactivations has also been evaluated to
study their clinical implications with IL-1β, PGE2, or
TNF-α levels showing an initial increase, both in continu-
ous and interrupted force [28,37]. However, timely reacti-
vations in interrupted force led to an upregulation of
these mediators, indicative of greater inflammation than
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in accordance with other studies that support association
of light continuous forces for OTM with minimal inflam-
mation, root resorption, and hyalinization of the peri-
odontal ligament [71-73]. More recent techniques for
accelerated orthodontics like micro-osteoperforations
have also conducted studies at cellular level that led to in-
crease in GCF levels of cytokines ( IL-1α, IL-1β, IL-6,
TNF-α) and chemokines at 24 h, giving evidence of under-
lying inflammatory process associated with inducing perfo-
rations in cortical bone [53]. An animal study further
supports the release of proinflammatory cytokines with
micro-osteoperforations, known to recruit osteoclast pre-
cursors and hence increase OTM by influencing the bone
remodeling process [74].
Results of the review showed that compression side
witnessed a decrease in bone-formative OPG by 24 h
[48] and increase in bone-resorptive RANK and TGF-β1
after 7 days [32,48]. Other mediators showing temporal
variation on compression side were IL-1β that increased
as early as 1 min [50] or after 4 h [47], RANKL after
42 days [47] or after 24 h both in juveniles and adults
[30], and IL-8 after 4 h [47] or after 10 days [36]. In con-
trast, the tension site showed an appreciable increase in
TNF-α [47] and other bone-resorbing mediators like IL-
1β, PGE2, and IL-8. But the rise occurred earlier than
compression and at all observation points with levels
higher than at the compression site [36,47]. This differ-
ence is hard to understand as the concept of compres-
sion on one side and tension on the other side of the
tooth undergoing movement is hypothetical. It has been
logically contradicted since the anatomical shape and
surface morphology of the tooth root cannot be consid-
ered confined to definite geometry. Thus, forces when
applied lead to biological response in whole of the peri-
odontal apparatus that cannot be differentiated for re-
lease of inflammatory mediators in GCF which is a
freely circulating fluid in gingival sulcus. Therefore, me-
diator levels in GCF collected from mesial or distal sites
of the tooth may not be indicative solely of compression
or tension zone activity.
Synopsis of the studies included in the review also re-
vealed that age and growth status were factors influen-
cing the level of cytokines in GCF that is shown to have
an effect on the rate and amount of tooth movement.
Mediator levels were seen to vary with growth status of
individuals as evaluated in adolescents and adults [57] or
compared in juveniles and adults [30,38]. In one study,
different mediators were found to increase in different
age groups with IL-6, GM-CSF increasing only in juve-
niles while PGE2 increasing both in juveniles and adults
[38]. In addition, activity index (AI) that is the ratio of
IL-1β/IL-1RA in GCF, was found to influence velocity
(Vt) of OTM both in growers and non-growers [35].Mean Vt of growers was 0.050 mm/day and of non-
growers was 0.024 mm/day for the same amount of applied
stress that was correlated with higher levels of IL-1β and an
increased AI in growers [35]. A greater Vt and amount of
OTM in juveniles as compared to adults could be explained
on the basis of a higher RANKL/OPG ratio in GCF in juve-
niles [30]. Other studies also support the variation in Vt ac-
cording to varying mediator levels and AI in GCF
[24,35,40,56]. It was found that association between AI
and Vt was stronger from distal than from mesial of
retracted teeth, thus emphasizing greater values of IL-
1β on the distal [40]. Thus, evidence from this literature
review emphasizes the role of RANKL/OPG ratio in
OTM in either of the age groups owing to its signifi-
cance in osteoclastogenesis and bone resorption that ul-
timately alters the amount and velocity of OTM.
Secondary outcome of this review was the association
of intensity of pain with different force levels. The level
of IL-1β was seen to increase at 1 day [50] that corre-
lated with increased pain intensity and subsequently,
there was a decrease seen in 7 days. Another study sug-
gested pain was less with 50-g force as compared to
150-g force that was correlated with greater levels of IL-
1β with application of 150-g force [22]. It can be con-
cluded that 150-g force is marked by higher levels of
IL-1β in GCF compared to 50-g force and high pain
intensity.
Conclusions
This systematic review is focused on association of cyto-
kine and receptor levels or activity index in GCF with vel-
ocity of tooth movement, nature of force applied, pain
intensity, and growth status/age of the subjects, leading to
following conclusions:
1. Application of orthodontic forces causes an
immediate release of inflammatory bone-resorptive
mediators (IL-1β, TNF-α) in 1 h that reach peak in
24 h, thus supporting the role of inflammation in
initial OTM.
2. Bone-forming mediators like OPG witnessed a fall in
levels immediately after orthodontic force
application indicating bone resorption to be the key
process in initiating tooth movement.
3. The levels of cytokines decrease after attaining peak
values, mostly at 24 h in continuous forces but
repeated activations in interrupted force upregulate
their secretion.
4. A rise in GCF levels of IL-1β with higher force levels
(150 vs 50 g) has been linked to increased pain
intensity during OTM.
5. Juveniles exhibiting greater RANKL/OPG ratio and
activity index (AI) (IL-1β/IL-1RA) in GCF displayed
faster rate of OTM than adults or non-growers.
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correlated with a greater activity index (AI) in GCF.
The literature search and critical review have also pro-
vided a lead to lacunae of the research in this field.
There is lack of uniformity of study design with respect
to sample size, age, sex ratio, observation intervals, dur-
ation of observations, mechanism employed to initiate
OTM and ethnic/nutritional barriers. These are potential
confounders which can influence the outcome [75]. A
major drawback identified in the current review was the
lack of consideration of sex on mediator levels that are
known to be sensitive to estrous cycle. Animal studies
have evaluated correlation between ovarian activity and
PGE2, IL-1β levels in GCF of female cats during OTM.
Results revealed that mediator levels of estrous groups
were lower than anestrous and ovariectomized groups on
6 and 12 days, indicating that ovarian activity can affect
OTM [76]. The threshold levels of the inflammatory me-
diators for initiation for OTM also remain unexplored. Be-
sides GCF, peri-implant fluid may also be a potential
medium to study these markers noninvasively in future
studies [77]. Search of pain killers having least effect on
bone-resorbing mediator levels as a drug of choice may be
a potential area of future research [78]. Research related
to the role of mediators in external apical root resorption
(EARR) and relapse has also received little attention
and are important research areas requiring further
exploration.
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